Hotline:
+ 49 (0) 2204 2918806

Market studies for category S

Items 1 to 10 of 424 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 43
  1. Net price*
    Year
  2. $250.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Embera NeuroTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    18 pages
    Embera NeuroTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances ProfileSummaryEmbera NeuroTherapeutics, Inc. (Embera) is a US-based development stage pharmaceutical company, that focuses on novel treatment of addictions and obesity. It develops treatments for smoking cessation and other addictions, for which there are
    Englisch | Deals and Alliances Profile | SKU: 304239
  3. $1,000.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    SIGVARIS, Inc. Market Share Analysis

    GlobalData
    20 pages
    Introduction GlobalData’s new report, “SIGVARIS, Inc. Market Share Analysis” provides in-depth information on SIGVARIS, Inc.’s market position in the wound care management market. The report also provides data and information on the overall competitive landscape within the wound care management market. The report is supplemented w
    Englisch | Report | SKU: 329601
  4. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Santen Pharmaceutical Co., Ltd. (4536) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    55 pages
    Santen Pharmaceutical Co., Ltd. (Santen) is a Japan-based pharmaceutical company. It conducts research and development, manufacture pharmaceuticals, over-the-counter (OTC) drugs and medical devices to protect and improve people's eyesight and health. The company specializes in the field of ophthalmology. Santen’s product portfolio inclu
    Englisch | Zukunftsanalyse | SKU: 331795
  5. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Spectros Corporation - Medical Equipment - Deals and Alliances Profile

    GlobalData
    17 pages
    Spectros Corporation (Spectros) is a medical device company. The company develops molecular sensing and imaging devices. Its T-Stat is the medical device to be labeled by the FDA as sensitive to ischemia. The company’s T-Stat VLS Tissue Oximeter provides a continuous, non-invasive and localized measurement, sensitive to regional and glo
    Englisch | Zukunftsanalyse | SKU: 269654
  6. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    SARcode Bioscience, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    21 pages
    SARcode Bioscience, Inc. (SARcode) is a pharmaceuticals and healthcare company, based in the US. The company operates through Drug Manufacturing. It develops small molecule LFA-1 inhibitors for the treatment of inflammatory diseases. The LFA-1 antagonists provide the mechanism action of an antibody (LFA-1/ICAM antagonism) with no safety i
    Englisch | Zukunftsanalyse | SKU: 387858
  7. $250.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Hyosung Corporation (004800) - Financial and Strategic SWOT Analysis Review

    GlobalData
    36 Pages
    SummaryHyosung Corporation (Hyosung) manufactures power systems and industrial machinery, and produces and trades in textile, chemical, industrial and construction products. The company develops motors, gear reducers and generators for power plants and supplies AC and DC motors and industrial machinery products. It deals in various towers
    Englisch | Strategy and SWOT Report | SKU: 279842
  8. $250.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Solvay Pharmaceuticals S.A. - Medical Equipment - Deals and Alliances Profile

    GlobalData
    16 pages
    Solvay Pharmaceuticals S.A. - Medical Equipment - Deals and Alliances ProfileSummarySolvay Pharmaceuticals S.A.) Solvay S.A. is a Belgian chemical company. It was founded in 1863 by Ernest Solvay to produce sodium carbonate by the solvay process. Since then the company has diversified to two major sectors of activity: chemicals and plasti
    Englisch | Deals and Alliances Profile | SKU: 304133
  9. $250.00
    2012
    Für diese Studie liegt keine Bewertung vor.

    Legend Mining Limited (LEG) - Financial and Strategic SWOT Analysis Review

    GlobalData
    33 Pages
    Legend Mining Limited (LEG) - Financial and Strategic SWOT Analysis Review Summary Legend Mining Limited (Legend) is an Australian mining and exploration company. It principally focuses on the discovery of iron ore, base metal and precious metal deposits at its project areas in Western Australia and Cameroon. In Western Australia, the c
    Englisch | Strategy and SWOT Report | SKU: 84317
  10. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Sosei Co. Ltd. (4565) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    20 pages
    Sosei Co. Ltd. (Sosei) is a biopharmaceutical company. The company develops and commercializes drugs. It commercializes its products throughout-licensing. The company’s product pipeline includes NorLevo, NVA237, QVA149 and SO-1105. Sosei’s NorLevo is an oral emergency contraceptive to prevent unwanted pregnancy. It markets products th
    Englisch | Zukunftsanalyse | SKU: 331150
  11. $250.00
    2014
    Für diese Studie liegt keine Bewertung vor.

    Senesco Technologies, Inc. (SNTI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

    GlobalData
    59 Pages
    Senesco Technologies, Inc. (Senesco) is a cancer therapeutic company. The company provides eukaryotic translation initiation Factor 5A (eIF5A) technology to regulate cell death and survival. It offers products and technologies in the areas of eIF5A, cancer, and inflammation. Senesco’s therapeutic candidate, SNS01-T comprises three compo
    Englisch | Zukunftsanalyse | SKU: 159757

Items 1 to 10 of 424 total

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 43